trial · primary record
Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg
Chronic Obstructive Pulmonary Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1252 |
| Primary completion | 2028-08 |
| Primary endpoint | Change to morning pre-dose FEV1 |
| Registry ID | NCT06234345 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:29.141Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06234345
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.